CARLSBAD, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CALIFORNIA TRANSPLANT SERVICES INC, founded in 1994, is a community nonprofit in the Health Care sector that reported $2.2M in total revenue in fiscal year 2023. The organization ran a surplus of $702K, a strong 32% operating margin.
THE MISSION OF CALIFORNIA TRANSPLANT SERVICES, INC. IS TO ACT AS A RESPONSIBLE STEWARD ON BEHALF OF OUR COMMUNITY OF ANATOMICAL DONATIONS THAT ARE GIFTED FOR TRANSPLANT AND RESEARCH; GIFTS THAT ARE GIVEN SELFLESSLY BY VERY SPECIAL PEOPLE SO OTHERS MAY ENJOY A LONGER AND BETTER QUALITY OF LIFE.
100% OF PROGRAM SERVICE REVENUE FOR 2023 WAS RECEIVED FROM FEES FOR SERVICES RELATED TO EYE AND TISSUE BANKING ACTIVITIES. CTS DISTRIBUTES OCULAR TISSUE FOR SIGHT RESTORATIVE SURGERIES. OCULAR TISSUE...
100% OF PROGRAM SERVICE REVENUE FOR 2023 WAS RECEIVED FROM FEES FOR SERVICES RELATED TO EYE AND TISSUE BANKING ACTIVITIES. CTS DISTRIBUTES OCULAR TISSUE FOR SIGHT RESTORATIVE SURGERIES. OCULAR TISSUE CTS DISTRIBUTES IS RECOVERED AND PROCESSED BY EYE BANKS THAT ARE REGISTERED WITH THE FDA & MEMBERS OF THE EYE BANK ASSOCIATION OF AMERICA. CTS ALSO DISTRIBUTES ALLOGRAFT TISSUE FOR RECONSTRUCTIVE SURGERY. ALLOGRAFT TISSUE DISTRIBUTED BY CTS IS RECOVERED AND PROCESSED BY TISSUE BANKS THAT ARE ACCREDITED MEMBERS OF THE AMERICAN ASSOCIATION OF TISSUE BANKS, AND REGISTERED WITH THE FDA. CTS IS A NATIONAL REPOSITORY OF AUTOLOGOUS CRANIAL BONE FLAPS RECOVERED FROM LIVING PATIENTS DURING MEDICAL AND TRAUMATIC SURICAL PROCEDURES FOR REIMPLANTATION AT A LATER TIME. CTS PROVIDES HOSPITAL IN-SERVICE EDUCATION, HOSPITAL STAFF TRAINING, DOCUMENTATION, CRYOGENIC STORAGE, AND AUTOLOGOUS INTER-FACILITY TISSUE ESCORT SERVICES IN VALIDATED CONTAINERS FOLLOWING PROCEDURES MANDATED BY THE FDA. CTS IS REGISTERED WITH, AND SUBJECT TO THE REGULATORY AUTHORITY OF THE US FOOD AND DRUG ADMINISTRATION FOR THE DISTRIBUTION AND STORAGE OF HUMAN ALLOGRAFT AND AUTOLOGOUS TISSUE. CTS IS LICENSED AS A TISSUE BANK BY THE STATE OF CALIFORNIA DEPARTMENT OF HEALTH, IS A MEMBER OF THE EYE BANK ASSOCIATION OF AMERICA AND IS AN ACCREDITED INSTITUTIONAL MEMBER OF THE AMERICAN ASSOCITATION OF TISSUE BANKS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $2,200,834 | $2,121,991 | +0.0% |
| Expenses | $1,498,625 | $1,490,979 | +0.0% |
| Net Income | $702,209 | $631,012 | +0.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| SUSAN DEBRHUL | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRISTIE HORN ESQ | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MARC PABLO CEBT CTBS MICP | SR VP, BOARD MEMBER | 65.00 |
Officer
Director
|
$303,150 | $14,938 | $318,088 |
| DARYL LIRMAN CTBS | CEO/BOARD MEMBER | 65.00 |
Officer
Director
|
$302,760 | $15,085 | $317,845 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $2,200,834 | $1,498,625 | $11,052,767 | $702,209 |
| 2022 | $2,121,991 | $1,490,979 | $10,227,193 | $631,012 |
| 2021 | $1,276,251 | $1,464,228 | $9,444,611 | $-187,977 |
| 2020 | $2,697,772 | $1,409,590 | $9,829,874 | $1,288,182 |
| 2019 | $1,998,069 | $1,539,259 | $8,457,431 | $458,810 |
| 2018 | $1,918,736 | $1,501,547 | $7,986,860 | $417,189 |
Compare CALIFORNIA TRANSPLANT SERVICES INC with other nonprofits in California and across the country.